NASDAQ:IBBQ Invesco Nasdaq Biotechnology ETF (IBBQ) Price, Holdings, & News $20.43 +0.07 (+0.34%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$20.42 0.00 (-0.02%) As of 05/23/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock About Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get IBBQ alerts:Sign Up Key Stats Today's Range$20.25▼$20.4350-Day Range$18.67▼$22.4152-Week Range$17.84▼$24.84Volume10,124 shsAverage Volume17,271 shsMarket Capitalization$35.75 millionAssets Under Management$35.72 millionDividend Yield1.17%Net Expense Ratio0.19%Aggregate RatingModerate Buy ETF OverviewThe Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.Read More… Invesco Nasdaq Biotechnology ETF ExpensesTypeIBBQHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.19%0.57%0.57%0.54%0.53%Other Expenses0.00%0.30%0.48%0.42%0.51%Total Expense0.19%0.70%0.72%0.68%0.71%Fee Waiver0.00%-0.45%-0.49%-0.29%-0.54%Net Expense0.19%0.61%0.63%0.62%0.60% Receive IBBQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Invesco Nasdaq Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address IBBQ ETF News HeadlinesInvesco Nasdaq Biotechnology ETF declares quarterly distribution of $0.04021March 24, 2025 | msn.comInvesco Nasdaq Biotechnology ETF declares quarterly distribution of $0.0619December 23, 2024 | msn.comTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.May 24, 2025 | Porter & Company (Ad)Invesco Launches New ETFs Targeting AI, Cybersecurity, And Defense. Here's How Some Of Their Peers Have Performed In The Past YearNovember 7, 2024 | msn.comIBBQ Invesco Nasdaq Biotechnology ETFOctober 21, 2024 | seekingalpha.comUpstream Bio valued at $1.1 bln as shares jump in Nasdaq debutOctober 11, 2024 | reuters.comSee More Headlines IBBQ ETF - Frequently Asked Questions How have IBBQ shares performed this year? Invesco Nasdaq Biotechnology ETF's stock was trading at $21.52 at the start of the year. Since then, IBBQ shares have decreased by 5.1% and is now trading at $20.43. View the best growth stocks for 2025 here. Who are Invesco Nasdaq Biotechnology ETF's major shareholders? Invesco Nasdaq Biotechnology ETF's top institutional investors include Partners Capital Investment Group LLP (1.43%), Breakwater Capital Group (1.23%) and CreativeOne Wealth LLC (0.58%). How do I buy shares of Invesco Nasdaq Biotechnology ETF? Shares of IBBQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Invesco Nasdaq Biotechnology ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Invesco Nasdaq Biotechnology ETF investors own include Vanguard Total Stock Market ETF (VTI), Verizon Communications (VZ), CrowdStrike (CRWD), DocuSign (DOCU), Meta Platforms (META), NVIDIA (NVDA) and Shopify (SHOP). Fund Details IssuerInvesco Fund NameInvesco Nasdaq Biotechnology ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:IBBQ Inception Date6/11/2021 Fund ManagerPeter Hubbard, Michael Jeanette, Pratik Doshi, Tony Seisser Previous SymbolNASDAQ:IBBQ WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNasdaq Biotechnology Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings264 Fund Statistics Assets Under Management$35.69 million Average Daily Volume$0.00 Discount/Premium-0.03% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorInvesco Capital Management LLC CustodianThe Bank of New York Mellon Corporation DistributorInvesco Distributors, Inc. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerLatour Trading Options OptionableN/A Short Interest900 shs Miscellaneous Outstanding Shares1,750,000Beta0.69 Creation Unit10,000 Creation Fee$600.00 (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report Top 10 IBBQ HoldingsGilead Sciences (NASDAQ:GILD)Holding Weight: 8.30%Vertex Pharmaceuticals (NASDAQ:VRTX)Holding Weight: 8.21%Amgen (NASDAQ:AMGN)Holding Weight: 8.00%Regeneron Pharmaceuticals (NASDAQ:REGN)Holding Weight: 7.14%AstraZeneca (NASDAQ:AZN)Holding Weight: 4.52%Alnylam Pharmaceuticals (NASDAQ:ALNY)Holding Weight: 4.21%Biogen (NASDAQ:BIIB)Holding Weight: 2.11%argenx (NASDAQ:ARGX)Holding Weight: 2.06%Summit Therapeutics (NASDAQ:SMMT)Holding Weight: 1.97%Sanofi (NASDAQ:SNY)Holding Weight: 1.67%Full Holdings DetailsIBBQ Sector ExposureIBBQ Industry Exposure This page (NASDAQ:IBBQ) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersMarket chaos is the new normalIt happened again. Wall Street swung like a wrecking ball after Trump paused tariffs on smartphones, lapto...Augusta Precious Metals | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredTrump Quietly Planning $15 Trillion Crypto ShockerMost investors are still unaware, but I believe a new White House action may have quietly opened the floodgate...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | SponsoredMemorial Day Sale! 82% Off Disruptors and Dominators!Jensen Huang recently gave the keynote speech at the Consumer Electronics Show in Las Vegas. When the Nvidi...Weiss Ratings | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Nasdaq Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Nasdaq Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.